News

Public · Published

MYGN: Revenue per test and profitability improved sequentially as the prenatal sale refocuses the business

Myriad Genetics reported Q3 revenue of $202.7 million, sequential increases in average revenue per test and improved adjusted EBITDA, while prenatal declines continued. It plans to sell its prenatal business for more than $210 million plus inventory, and raised the midpoint of its FY2026 revenue outlook to $785 million.

Published:

Updated:

What happened

Myriad Genetics reported Q3 revenue of $202.7 million, sequential increases in average revenue per test and improved adjusted EBITDA, while prenatal declines continued. It plans to sell its prenatal business for more than $210 million plus inventory, and raised the midpoint of its FY2026 revenue outlook to $785 million.

Confirmed

Global impact / market context

The planned sale would shift Myriad’s focus toward cancer and mental health testing. Proceeds from the transaction could provide cash for those areas or other business needs, while giving up prenatal revenue makes the company’s ability to grow its remaining tests more important.

Analyst inference

Sequentially higher revenue per test and adjusted EBITDA suggest improvement in those measures, but the article gives no year-over-year comparison or figures for profit. The higher FY2026 revenue midpoint points to a stronger forecast, while continuing prenatal declines remain a transition risk.

Analyst inference

What to watch

  1. Whether Myriad completes the planned prenatal sale for more than $210 million plus inventory, and when the transaction closes, since the article provides no closing date. Confirmed
  2. Whether cancer and mental health testing can support revenue after the prenatal business is sold; the article says the sale sharpens focus but gives no growth figures. Analyst inference
  3. Whether Myriad meets its FY2026 revenue outlook, whose midpoint is $785 million, and whether average revenue per test and adjusted EBITDA continue improving sequentially. Analyst inference

Evidence

  • Original source link unavailable